Vincristine Sulfate for Injection
»Vincristine Sulfate for Injection is a sterile mixture of Vincristine Sulfate with suitable diluents.It contains not less than 90.0percent and not more than 110.0percent of the labeled amount of vincristine sulfate (C46H56N4O10·H2SO4).
[Caution—Handle Vincristine Sulfate for Injection with great care since it is a potent cytotoxic agent. ]
Packaging and storage— Preserve in Containers for Sterile Solidsas described under Injections á1ñ,in a refrigerator.
Labeling— The label states:“FATAL IF GIVEN INTRATHECALLY.FOR INTRAVENOUS USE ONLY.”Where labeled as containing more than 2mg,it must also be labeled as a Pharmacy Bulk Package(see Injections á1ñ).The labeling directs that the drug be dispensed only in containers enclosed in an overwrap labeled as directed below.When packaged in a Pharmacy Bulk Package,it is exempt from the requirement under Injections á1ñ,that the closure be penetrated only one time after constitution with a suitable sterile transfer device or dispensing set,when it contains a suitable substance or mixture of substances to prevent the growth of microorganisms.
When dispensed,the container or syringe (holding the individual dose prepared for administration to the patient)must be enclosed in an overwrap bearing the statement “DO NOT REMOVE COVERING UNTIL MOMENT OF INJECTION.FATAL IF GIVEN INTRATHECALLY.FOR INTRAVENOUS USE ONLY.”
Constituted solution— At the time of use,it meets the requirements for Constituted Solutionsunder Injections á1ñ.
Identification—
Spray reagent— Dissolve 2.0g of ceric ammonium sulfate in 100mLof water with heating and stirring,and slowly add 100mLof phosphoric acid.Filter if necessary.
Procedure— Dissolve a sufficient quantity in water to obtain a solution containing 25mg per mL.Further dilute the solution to 10mg per mLwith methanol,and mix.Also prepare a 10-mg-per-mLsolution of USP Vincristine Sulfate RSin a mixture of dichloromethane and methanol (3:1),and mix.Use a thin-layer chromatographic plate coated with a 0.25-mm layer of chromatographic silica gel mixture (see Chromatography á621ñ).Develop it in a methanol prewash tank,and dry it,for maximum sensitivity,not more than 2hours before use.Score it about 15cm above the points of application.Apply 20µLof each solution at points about 2.5cm from the lower edge of the plate,and dry thoroughly (a current of cool air may be used to help dry the spots).Prepare the developing solvent system consisting of a mixture of fresh ether,methanol,and methylamine solution (2in 5)(95:10:5)immediately prior to development.Place the plate in the nonequilibrated developing chamber that contains a paper liner around the back and sides and developing solvent to a depth of about 2cm.Remove the plate when the solvent moves to the scored line (about 80minutes),and discard the solvent system.Dry the plate in a fume hood at room temperature,heat on a metal plate on a steam bath for about 15minutes,and spray the plate while still hot with Spray reagent.Continue heating the plate for 15minutes to stabilize the spots:the RFvalue and the color of the principal spot obtained from the test specimen correspond to those obtained from the Reference Standard.
Bacterial endotoxins á85ñ It contains not more than 100.0USP Endotoxin Units per mg of vincristine sulfate.
Uniformity of dosage units á905ñ It meets the requirements for solids.
Procedure for content uniformity—
Buffer solution— Dissolve 6.3g of ammonium formate in about 900mLof water in a 1000-mLvolumetric flask,adjust with formic acid to a pHof 5.0while stirring,dilute with water to volume,and mix.
Standard preparation— Dissolve an accurately weighed quantity of USP Vincristine Sulfate RSin Buffer solution,and dilute quantitatively and stepwise with Buffer solutionto obtain a solution having a known concentration of about 40µg per mL.
Test preparation— Dissolve the contents of 1container of Vincristine Sulfate for Injection in an accurately measured volume of Buffer solutionto obtain a solution having a concentration between 40and 50µg per mL.
Procedure— Concomitantly determine the absorbances of the Test preparationand the Standard preparationin 1-cm cells at the wavelength of maximum absorbance at about 262nm versus the Buffer solutionas the blank.Calculate the quantity,in mg,of C46H56N4O10·H2SO4in the container taken by the formula:
0.001CV(AU/AS),
in which Cis the concentration,in µg per mL,of USP Vincristine Sulfate RS(corrected for loss in weight)in the Standard preparation,Vis the volume,in mL,to which the contents of the container are diluted,and AUand ASare the absorbances of the Test preparationand the Standard preparation,respectively.
Related compounds— Proceed as directed in the test for Related compoundsunder Vincristine Sulfate.The total of the responses due to related substances does not exceed 5.0%,and no single related substance response exceeds 2.0%.
Other requirements— It meets the requirements for Sterility Tests á71ñ,and for Labelingunder Injections á1ñ.
Assay—
Mobile phase,Standard preparation,System suitability preparation,andChromatographic system— Prepare as directed in the Assayunder Vincristine Sulfate.
Assay preparation— Pipet a suitable volume of water into a container of Vincristine Sulfate for Injection to obtain a solution having a concentration of about 1mg of vincristine sulfate per mL.Insert the stopper,and shake to mix.
Procedure— Proceed as directed for Procedurein the Assayunder Vincristine Sulfate.Calculate the quantity,in mg,of vincristine sulfate (C46H56N4O10·H2SO4)in the portion of Vincristine Sulfate for Injection taken by the formula:
10C(rU/rS),
in which Cis the concentration,in mg per mL,of USP Vincristine Sulfate RScorrected for loss in weight in the Standard preparation;and rUand rSare the peak responses for vincristine sulfate obtained from the Assay preparationand the Standard preparation,respectively.
Auxiliary Information— Staff Liaison:Lawrence Evans,III,Ph.D.,Scientist
Expert Committee:(PA6)Pharmaceutical Analysis 6
USP28–NF23Page 2026
Phone Number:1-301-816-8389